RD

Active Director Director DIN 08050006
DIN 08050006 First appointment Apr 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Renu Dey

Data last updated:

Renu Dey is a Director at Seba Sebak Hospital Private Limited (since 2018). The company operates in Healthcare.

DIN 08050006
Primary Designation Director
Industry Healthcare
First Appointment 06 Apr 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Seba Sebak Hospital Private Limited U74999WB2018PTC225520
Director06 Apr 20182018Active

Directorship timeline

Open interactive timeline →
Seba Sebak Hospital Private Limited
Premium access

Shareholding and investment profile for Renu Dey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu Dey

Renu Dey currently holds 1 directorship: Seba Sebak Hospital Private Limited (Director, since 06 Apr 2018).

Renu Dey was first appointed on 06 Apr 2018 as Director at Seba Sebak Hospital Private Limited.

The current boards of Renu Dey's companies include Jayanta Narayan De (Seba Sebak Hospital Private Limited), Kishore Chatterjee (Seba Sebak Hospital Private Limited), Piyali Chakraborty (Seba Sebak Hospital Private Limited), Raktim Dey (Seba Sebak Hospital Private Limited), Sanjoy Dasgupta (Seba Sebak Hospital Private Limited), Shivam Anand (Seba Sebak Hospital Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available